久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Reporter's Journal

Conquering malaria remains a daunting dilemma, but there's hope

By Chris Davis | China Daily USA | Updated: 2017-04-27 11:18
Share
Share - WeChat

The war against malaria has made progress over the past decade, but there is still a long way to go, and Chinese researchers are leading the way on more than one front.

Roughly half of the world's population - 3 billion people - still remains at risk.

In 2006, there were 266 million cases a year leading to 750,000 deaths, according to the World Health Organization.

By 2015, the numbers had diminished, but remained huge - 212 million cases, 429,000 deaths.

And a staggering 90 percent of all cases are in Africa.

Dr Deng Changsheng, manager of the department of science and technology at Guangzhou University of Chinese Medicine, told a group of 27 journalists visiting from Africa recently, that strategy used to cause a major decline in malarial regions of China is showing promise in Africa.

The approach is called fast elimination of malaria by source eradication (FEMSE). It involves mass drug administration (MDA) of artemisinin-based combination therapies (ACT) - in other words, clearing an affected population of the malarial parasites by mass drug administration.

Artemisinin, by the way, is the drug that won 85-year-old Chinese pharmacologist Tu Youyou the 2015 Nobel Prize for Medicine. She had mined the recipe, derived from the sweet wormwood plant, from the annals of ancient Chinese medicine. Today it saves hundreds of thousands of lives a year in Africa alone.

The drug has not been cheap, but Deng said the cost could be brought to as low as $15 per person over the next decade. Today it's about $40, according to Deng.

Thanks to a worldwide push, ACT treatments rose from 187 million in 2010 to 311 million in 2015.

The big fear facing the effort right now is that the parasites are showing signs of developing a resistance to artemisinin, the same way some strains of tuberculosis are shunning off some of modern medicine's most potent antibiotics.

"The spread of artemisinin resistance in Africa would be a major setback in the fight against malaria, as ACT is the only effective and widely used anti-malarial treatment at the moment," writes Professor Arnab Pain of King Abdullah University of Science and Technology in the current issue of the New England Journal of Medicine.

"Therefore it is very important to regularly monitor artemisinin resistance on a worldwide scale," he added.

The study, led by Jun Cao of the Institute for Parasitic Diseases in China, found drug-resistant malarial parasites in a Chinese patient who had been in Equatorial Guinea and returned to China. The ACT therapy, which usually takes three days to rid the patient of the disease, took five days in this case.

This "partial resistance", they said, has been noted in other parts of Southeast Asia, and the great fear is that "partial" morphs into "complete".

"This is one of the great challenges facing us in the fight against malaria," the World Health Organization says on its website.

The holy grail of that fight, of course, remains a vaccine, and The Associated Press reports that three African nations have just been chosen to test the world's first malaria vaccine.

WHO announced Monday that Ghana, Kenya and Malawi will begin piloting an injectable vaccine next year with hundreds of thousands of young children, who have been at highest risk of death.

The vaccine, which has partial effectiveness, has the potential to save tens of thousands of lives if used with existing measures, WHO's regional director for Africa, Dr Matshidiso Moeti, said in a statement. The challenge is whether impoverished countries can deliver the required four doses of the vaccine for each child.

The vaccine will be tested on children 5 to 17 months old to see whether its protective effects shown so far in clinical trials can hold up under real-life conditions. At least 120,000 children in each of the three countries will receive the vaccine, which has taken decades of work and hundreds of millions of dollars to develop.

Kenya, Ghana and Malawi were chosen for the vaccine pilot because all have strong prevention and vaccination programs but continue to have high numbers of malaria cases, WHO said. The countries will deliver the vaccine through their existing vaccination programs.

WHO is hoping to wipe out malaria by 2040, despite the increasing resistance problems to both drugs and insecticides used to kill mosquitoes.

The vaccine was developed by GlaxoSmithKline, and the $49 million for the first phase of the pilot is being funded by the global vaccine alliance GAVI, UNITAID and Global Fund to Fight AIDS, Tuberculosis and Malaria.

Contact the writer at chrisdavis@chinadailyusa.com.

 

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    亚洲免费在线播放| 久久国产福利国产秒拍| 欧美三级电影在线观看| 亚洲va国产va欧美va观看| 91精品国产综合久久婷婷香蕉| 日韩1区2区日韩1区2区| 精品盗摄一区二区三区| 日韩亚洲欧美在线观看| 久草热8精品视频在线观看| 国产女人18毛片水真多成人如厕 | 欧美精品一二三区| 国产真实乱子伦精品视频| 国产欧美1区2区3区| 94色蜜桃网一区二区三区| 性欧美疯狂xxxxbbbb| 欧美成人a∨高清免费观看| 成人午夜大片免费观看| 亚洲午夜久久久久久久久久久| 日韩午夜精品视频| 成人国产精品免费网站| 亚洲福利一二三区| 久久人人超碰精品| 日本丶国产丶欧美色综合| 美女任你摸久久| 中文字幕亚洲视频| 欧美高清视频在线高清观看mv色露露十八 | 首页国产丝袜综合| 欧美激情一区三区| 欧美无砖砖区免费| 国产又黄又大久久| 亚洲精品久久嫩草网站秘色| 欧美一区二区视频免费观看| 懂色av一区二区在线播放| 性做久久久久久免费观看欧美| 久久综合久久综合久久综合| 91麻豆国产精品久久| 九色porny丨国产精品| 一区二区三区在线视频观看| 久久久三级国产网站| 欧美日韩免费观看一区三区| 国产成人综合网站| 日日夜夜精品视频免费| 国产精品蜜臀av| 3d动漫精品啪啪1区2区免费| 成av人片一区二区| 久久精品国产亚洲高清剧情介绍 | 激情六月婷婷久久| 亚洲国产综合视频在线观看| 国产视频一区二区三区在线观看| 欧美日韩另类国产亚洲欧美一级| 盗摄精品av一区二区三区| 视频一区欧美日韩| 亚洲欧美另类在线| 国产丝袜美腿一区二区三区| 在线不卡a资源高清| 91网站黄www| 国产一区不卡在线| 日韩av一区二区在线影视| 亚洲另类春色国产| 中文字幕欧美日本乱码一线二线| 日韩欧美在线综合网| 欧美色综合网站| 99久久免费视频.com| 国产精品一区二区三区四区| 蜜臀99久久精品久久久久久软件| 亚洲一区二区三区自拍| 综合精品久久久| 欧美国产日本韩| 精品国一区二区三区| 欧美一区二区黄| 欧美日韩亚州综合| 在线观看免费视频综合| 成人黄色一级视频| 高清不卡一二三区| 国产精品99久久久久久宅男| 免费观看日韩电影| 日本中文一区二区三区| 午夜久久久久久| 亚洲午夜激情网页| 一区二区三区免费| 亚洲色图丝袜美腿| 亚洲特黄一级片| 国产精品欧美久久久久一区二区| 久久先锋影音av鲁色资源网| 日韩一区二区三区在线观看| 4438x成人网最大色成网站| 欧美日韩亚洲丝袜制服| 欧美私人免费视频| 欧美在线观看视频在线| 在线精品观看国产| 日本道免费精品一区二区三区| 97久久精品人人做人人爽| www.性欧美| 成人av高清在线| a级精品国产片在线观看| 国产成人精品免费一区二区| 国产成a人亚洲精| 成人免费黄色大片| av电影天堂一区二区在线观看| 不卡的av中国片| 91丨porny丨中文| 93久久精品日日躁夜夜躁欧美| 99精品热视频| 欧美影院一区二区| 精品视频999| 欧美一区二区三区在线观看| 91麻豆精品国产无毒不卡在线观看| 欧美丰满高潮xxxx喷水动漫| 欧美一卡在线观看| 久久综合久久综合久久综合| 久久久99精品免费观看不卡| 国产精品视频yy9299一区| 亚洲丝袜自拍清纯另类| 亚洲永久免费视频| 天天色综合天天| 久久99九九99精品| 国产大陆亚洲精品国产| 99视频一区二区三区| 日本韩国欧美在线| 国产日韩亚洲欧美综合| 色婷婷综合久色| 欧美影院午夜播放| 91麻豆精品久久久久蜜臀| 日韩一级片在线观看| 久久综合五月天婷婷伊人| 国产婷婷一区二区| 亚洲欧美一区二区三区极速播放 | 国产精品女主播在线观看| 国产精品久久久久久久久快鸭| 亚洲日本va在线观看| 亚洲成人免费在线| 久久精品国产久精国产| 国产综合色视频| 91视频国产观看| 欧美久久婷婷综合色| 精品处破学生在线二十三| 国产精品久久夜| 午夜日韩在线电影| 韩国一区二区在线观看| 不卡视频一二三四| 欧美理论电影在线| 久久久不卡影院| 亚洲激情自拍视频| 美女视频一区在线观看| 成人一区二区三区视频在线观看 | 久久久久久久久免费| 1024成人网色www| 午夜电影久久久| 国产成人亚洲综合色影视| 91麻豆国产在线观看| 日韩欧美在线不卡| 亚洲丝袜美腿综合| 麻豆国产精品777777在线| 成人看片黄a免费看在线| 欧美日本一区二区三区| 国产日韩欧美在线一区| 亚洲成人福利片| 国产不卡视频在线观看| 欧美日韩第一区日日骚| 国产视频一区二区在线| 午夜精品aaa| 成人av网站免费| 日韩欧美久久久| 亚洲日本在线天堂| 国产在线精品一区二区夜色 | 国产精品久久久久久亚洲伦| 另类调教123区| 成人国产亚洲欧美成人综合网| 欧美日韩精品福利| 国产精品午夜在线| 日本视频在线一区| 成人免费黄色大片| 日韩三级在线免费观看| 亚洲精品欧美二区三区中文字幕| 美女一区二区在线观看| 色婷婷激情综合| 国产色产综合产在线视频| 性欧美大战久久久久久久久| 成人高清视频在线观看| 欧美mv和日韩mv国产网站| 亚洲精品视频一区二区| 国产福利精品一区| 日韩一级欧美一级| 亚洲小说欧美激情另类| 成人小视频在线| 欧美videossexotv100| 亚洲在线观看免费| 波多野结衣中文字幕一区二区三区| 日韩一卡二卡三卡四卡| 夜夜嗨av一区二区三区网页| 国产激情精品久久久第一区二区| 91精品国产欧美一区二区18| 亚洲综合激情小说| 99久久精品免费看国产免费软件| 亚洲精品一区二区精华| 天堂成人国产精品一区| 色伊人久久综合中文字幕| 国产精品传媒入口麻豆| 国产一区二区看久久| 日韩一级大片在线观看|